Snekha Rajasekaran, a biomedical sciences junior at the University of Alabama at Birmingham, gained monumental research ...

Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

LSU Health Shreveport School of Medicine students learned where they will go to complete their residency training during the ...

As the Trump administration threatens to pull federal funds from universities, including for medical and scientific research, ...

Accomplishments Eon is currently a Clinical Assistant Professor of Dermatology at Stanford University and an Attending ...

Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...

The FDA has approved a supplemental new drug application for the treatment of cardiomyopathy wild-type or hereditary transthyretin-mediated amyloidosis.

This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with ...

Health systems have experienced big challenges in the last year, with cyberattacks affecting thousands of hospitals, rising expenses, workforce shortages and fractured relationships with payers. With ...

The Hong Kong University of Science and Technology (HKUST) submitted its formal proposal to the government today for the establishment of Hong Kong's ...

The Food and Drug Administration (FDA) has approved Amvuttra ® (vutrisiran) for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to ...

It's called Match Day, and it's one of the most unforgettable moments in a doctor's life. This year, MedPage Today's Rachael ...